EGFR and non-small cell lung carcinoma: An inhibitor of miR-128b resulted in up-regulated EGFR expression in an EGFR-expressing NSCLC cell line, and treatment with a miR-128b mimic resulted in a concomitant reduction of EGFR expression[23].